Titan Biotech Share Price | Titan Biotech Stock Screener
TITANBIO
Specialty Chemicals
Share Price BSE
₹423.75
▼
-0.80 (-0.19%)
As of July 23, 2026, the Titan Biotech share price (BSE: TITANBIO) is ₹423.75, down 0.19% from the previous close, with shares trading between ₹403.35 and ₹429.95, and a 52-week range of ₹220.20–₹1,424.50.
Analyse TITANBIO share price data and track historical price performance.
Use the Titan Biotech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Titan Biotech Market Cap
₹1,762.63 Cr.
TITANBIO P/E Ratio (TTM)
58.76
Titan Biotech P/B Ratio
9.67
EPS (TTM)
₹7.23
Dividend Yield
0.12%
Debt to Equity
0.04
TITANBIO 52 Week High
₹1424.50
Titan Biotech 52 Week Low
₹220.20
Operating Margin
20.00%
Profit Margin
13.73%
TITANBIO Revenue (TTM)
₹51.00
EBITDA
₹12.00
Net Income
₹7.00
Total Assets
₹214.00
Total Equity
₹182.00
Titan Biotech Share Price Chart
Screen Titan Biotech share price with an interactive chart. Analyse TITANBIO price trends and volatility across different timeframes.
Titan Biotech Company Profile - Fundamental Screener
Screen Titan Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for TITANBIO shares.
Sector
Chemicals
Industry
Specialty Chemicals
Sub-Sector
Specialty Chemicals
Segment
E
ISIN
INE150C01029
Titan Biotech Balance Sheet Screener
Screen TITANBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 214 | 175 | 157 | 135 | 108 | 101 | 76 | 65 | 57 | 52 |
| Current Assets | 85 | 79 | 73 | 68 | 64 | 59 | 44 | 35 | 29 | 30 |
| Fixed Assets | 63 | 57 | 52 | 36 | 35 | 34 | 31 | 29 | 14 | 13 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 6 | 4 | 4 | 4 | 5 | 9 | 14 | 15 | 20 | 16 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 182 | 153 | 134 | 110 | 86 | 73 | 42 | 34 | 26 | 24 |
| Share Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves & Surplus | 173 | 145 | 125 | 102 | 78 | 61 | 31 | 24 | 17 | 15 |
Titan Biotech Income Statement Screener - Profit & Revenue Analysis
Screen Titan Biotech income statement and profit fundamentals.
Analyze TITANBIO quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Titan Biotech share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 51 | 37 | 47 | 56 | 58 | 40 | 44 | 40 | 40 | 37 | 35 | 44 | 46 | 33 | 35 |
| Expenses | 39 | 31 | 38 | 45 | 46 | 33 | 35 | 32 | 33 | 30 | 27 | 35 | 35 | 26 | 27 |
| EBITDA | 12 | 6 | 10 | 11 | 12 | 8 | 9 | 8 | 6 | 7 | 8 | 9 | 11 | 8 | 8 |
| Operating Profit % | 20.00% | 13.00% | 19.00% | 17.00% | 19.00% | 18.00% | 19.00% | 19.00% | 13.00% | 19.00% | 23.00% | 20.00% | 23.00% | 23.00% | 23.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 10 | 5 | 8 | 9 | 11 | 6 | 8 | 7 | 5 | 6 | 7 | 8 | 10 | 7 | 8 |
| Tax | 4 | 1 | 1 | 2 | 2 | 1 | 1 | 0 | 1 | 1 | 1 | 2 | 3 | 2 | 0 |
| Net Profit | 7 | 4 | 7 | 8 | 9 | 5 | 6 | 7 | 4 | 5 | 6 | 7 | 7 | 5 | 8 |
| EPS | 1.63 | 4.90 | 8.30 | 9.40 | 10.32 | 6.05 | 7.74 | 8.10 | 5.31 | 6.07 | 7.47 | 7.89 | 8.68 | 6.03 | 9.08 |
Titan Biotech Cash Flow Screener - Liquidity Fundamentals
Screen TITANBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 20 | 21 | 21 | 22 | 19 | 6 | 6 | 2 | 0 | 5 |
| Investing Activities | -10 | -20 | -21 | -16 | -5 | -2 | -4 | -6 | -8 | -5 |
| Financing Activities | -8 | -3 | -2 | -4 | -11 | -4 | 0 | 0 | 9 | 2 |
| Net Cash Flow | 2 | -2 | -2 | 2 | 4 | 0 | 1 | -3 | 1 | 2 |
Titan Biotech Shareholding Pattern Screener
See Titan Biotech shareholding pattern with promoter, FII, and DII holdings.
Check Titan Biotech promoter holding and ownership changes for TITANBIO on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 55.78% | 55.78% | 55.88% | 55.88% | 55.78% | 55.78% | 55.88% | 55.88% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.03% | 0.01% | 0.01% | 0.03% | 0.03% | 0.03% | 0.23% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 27.72% | 28.02% | 29.20% | 29.44% | 29.65% | 29.74% | 30.06% | 30.11% |
| Other Holding | 16.47% | 16.19% | 14.91% | 14.65% | 14.54% | 14.45% | 13.84% | 14.01% |
| Shareholder Count | 17,457 | 18,671 | 16,370 | 16,328 | 16,040 | 16,367 | 15,876 | 15,850 |
Titan Biotech Share Dividend Screener - Share Yield Analysis
Check Titan Biotech dividend history with payout and yield data.
View Titan Biotech dividend details including ex-dates and amounts for TITANBIO stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹2.00 | 0.44% |
| 2024-March | ₹2.00 | 2.37% |
| 2023-March | ₹1.80 | 1.70% |
| 2022-March | ₹1.50 | 3.81% |
| 2021-March | ₹1.50 | 2.86% |
| 2020-March | ₹1.00 | 2.69% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.75 | 8.33% |
| 2017-March | ₹0.75 | 5.96% |
Titan Biotech Stock Index Membership
See which indices include Titan Biotech stock.
Check TITANBIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Titan Biotech Market Events Screener - Corporate Actions
Get Titan Biotech corporate actions including splits, bonuses, and buybacks.
Check Titan Biotech stock events that may affect TITANBIO share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 5.29% |
| 2026-02-20 | 2025-11-29 | Split | 2:10 | 0.00% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 10.81% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -7.75% |
| 2025-09-26 | 2025-09-26 | Annual General Meeting | NA | 112.48% |
| 2025-09-19 | 2025-09-19 | Dividend | ₹ 2.00 /share | 102.73% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 2.29% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 0.55% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -7.10% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -4.87% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 14.27% |
| 2024-09-23 | 2024-09-24 | Dividend | ₹ 2.00 /share | 14.63% |
| 2023-09-22 | 2023-09-22 | Dividend | ₹ 1.80 /share | 41.88% |
| 2022-09-22 | 2022-09-23 | Dividend | ₹ 1.50 /share | 20.28% |
| 2021-09-16 | 2021-09-08 | Dividend | ₹ 1.50 /share | -15.22% |
Titan Biotech Competitors Screener - Peer Comparison
Screen TITANBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Pidilite Industries | 159,781 | 64.47 | 14,867 | 11.05% | 2,471 | 51.07 |
| SRF | 85,124 | 46.66 | 15,894 | 7.20% | 1,835 | 61.86 |
| Gujarat Fluorochemicals | 47,413 | 79.47 | 4,996 | 2.94% | 569 | 69.78 |
| Navin Fluorine International | 40,310 | 58.55 | 3,379 | 41.21% | 664 | 53.60 |
| Himadri Speciality Chemical | 38,845 | 46.53 | 4,832 | 3.60% | 755 | 68.67 |
| Deepak Nitrite | 23,046 | 42.33 | 7,887 | -5.72% | 566 | 58.26 |
| Aether Industries | 19,251 | 89.29 | 1,160 | 31.79% | 240 | 66.67 |
| Aarti Industries | 17,963 | 42.73 | 8,286 | 13.73% | 365 | 56.91 |
| Atul | 17,934 | 26.24 | 6,476 | 13.77% | 689 | 36.30 |
| BASF | 15,958 | 38.36 | 15,010 | 1.01% | 416 | 58.25 |
Titan Biotech Company Announcements - News Screener
Screen TITANBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-25 | Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) | - |
| 2026-06-23 | Closure of Trading Window | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-30 | Re-Appointment Of Cost Auditor For Financial Year 2026-2027 | - |
| 2026-05-30 | Corporate Action-Board to consider Dividend | - |
| 2026-05-30 | Result_Audited Financial Results For The Quarter And Year Ended March 31 2026 | - |
| 2026-05-30 | Board Meeting Outcome for Outcome Of The Board Meeting Of Titan Biotech Limited Held Today I.E. 30Th May 2026 | - |
| 2026-05-20 | Board Meeting Intimation for Approval Of The Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Year Ended March 31 2026 And To Recommend Dividend If Any On The Equity Shares Of The Company For The Financial Year 202 | - |
| 2026-05-06 | Intimation Regarding Second 100 Days Campaign - Saksham Niveshak | - |
| 2026-05-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-04 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-04-28 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-23 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-04-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-04-04 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-26 | Closure of Trading Window | - |
| 2026-02-27 | Intimation Of Credit Confirmation Of Equity Shares From Depositories With Regard To Sub-Division / Split Of Equity Shares Of The Company | - |
| 2026-02-17 | Re-Lodgement Of Transfer Requests Of Physical Shares | - |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |